EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype Structure Alterations in 5q SMA Patients as a Result of the Newborn Screening Program Implementation in the Russian Federation

Maria A Akhkiamova iD, Andrey V Marakhonov iD, Victoria V Zabnenkova iD, Kristina A Mikhalchuk iD, Sergei V Voronin iD, Sergey I Kutsev iD, Victoria V Musatova, Tatyana N Kekeeva iD, Nina V Ryadninskaya iD, Alena L Chukhrova iD, Svetlana I Braslavskaya, Polina A Chausova iD und 13 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria A Akhkiamova und 24 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moskvorechie Str., 1, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Neonatal Screening, Survival of Motor Neuron 1 Protein, Muscular Atrophy, Spinal, Survival of Motor Neuron 2 Protein. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 2023, the Russian Federation (RF) has implemented an expanded newborn screening (NBS) program for 36 hereditary disorders, which now includes 5q spinal muscular atrophy (5q SMA). As a result of newborn screening for 5q SMA conducted in the RF during 2023–2024, 288 newborns with a homozygous deletion of exon 7 in the SMN1 gene were identified by molecular genetic methods. The overall observed incidence of 5q SMA was 1 in 8439 newborns, which does not significantly differ from the expected incidence of 1 in 7953 newborns, established by previous pilot screening projects (p > 0.05). A comparison of the genotypes of patients identified through selective and newborn screening showed statistically significant differences in the proportions of patients carrying two, three, and four or more copies of the SMN2 gene. These findings demonstrate that the NBS program is effective in detecting both individuals with more severe phenotypes, as expected, and those with milder forms of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningSurvival of Motor Neuron 1 ProteinMuscular Atrophy, SpinalSurvival of Motor Neuron 2 ProteinHumansInfant, NewbornRussiaGenotypeMaleFemaleExons

Stichwörter der Autor:innen

5q SMASMN1 exon 7 deletiongenotypenewborn screeningnumber of SMN2 exon 7 copiesselective screeningspinal muscular atrophy 5q

Substanzen

Survival of Motor Neuron 1 ProteinSMN1 protein, humanSurvival of Motor Neuron 2 ProteinSMN2 protein, human

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, Moskvorechie Str., 1, 115522 Moscow, Russia.
  • FSAI "National Medical Research Centre for Children's Health", Lomonosovskiy Prospekt, 2 b.1, 119991 Moscow, Russia.
  • SBHI Republican Medical Genetic Centre, Gafuri St., 74, 450076 Ufa, Russia.
  • SPB SBHI "Diagnostic Centre (Medical Genetic)", Tobolskaya St., 5A, 194044 Saint-Petersburg, Russia.
  • FSBI "NMRC OGP Named After Academician V.I. Kulakov", Akademika Oparina St., 4, 117997 Moscow, Russia.
  • FSPSI "Scientific Centre for Family Health and Human Reproduction Problems", Timiryazeva St., 16, 664003 Irkutsk, Russia.

ORCID-Profile: Maria A Akhkiamova, Andrey V Marakhonov, Victoria V Zabnenkova, Kristina A Mikhalchuk, Sergei V Voronin, Sergey I Kutsev, Tatyana N Kekeeva, Nina V Ryadninskaya, Alena L Chukhrova, Polina A Chausova, Tatyana S Beskorovainaya, Aleksander V Polyakov, Kirill V Savostyanov, Ilya S Zhanin, Fanil S Bilalov, Alexander L Koroteev, Dmitry Y Trofimov, Tatyana A Bairova, Gulnara N Seitova, Sergei V Mordanov, Olga A Shchagina

Zitieren

APA

Akhkiamova, M. A., Marakhonov, A. V., Zabnenkova, V. V., Mikhalchuk, K. A., Voronin, S. V., Kutsev, S. I., Musatova, V. V., Kekeeva, T. N., Ryadninskaya, N. V., Chukhrova, A. L., Braslavskaya, S. I., Chausova, P. A., Beskorovainaya, T. S., Polyakov, A. V., Savostyanov, K. V., Zhanin, I. S., Bilalov, F. S., Koroteev, A. L., Trofimov, D. Y., …, & Shchagina, O. A. (2025). Genotype Structure Alterations in 5q SMA Patients as a Result of the Newborn Screening Program Implementation in the Russian Federation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167891

Vancouver

Akhkiamova MA, Marakhonov AV, Zabnenkova VV, Mikhalchuk KA, Voronin SV, Kutsev SI, et al. Genotype Structure Alterations in 5q SMA Patients as a Result of the Newborn Screening Program Implementation in the Russian Federation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167891

BibTeX
@article{Akhkiamova2025,
  author = {Akhkiamova, Maria A and Marakhonov, Andrey V and Zabnenkova, Victoria V and Mikhalchuk, Kristina A and Voronin, Sergei V and Kutsev, Sergey I and Musatova, Victoria V and Kekeeva, Tatyana N and Ryadninskaya, Nina V and Chukhrova, Alena L and Braslavskaya, Svetlana I and Chausova, Polina A and Beskorovainaya, Tatyana S and Polyakov, Aleksander V and Savostyanov, Kirill V and Zhanin, Ilya S and Bilalov, Fanil S and Koroteev, Alexander L and Trofimov, Dmitry Y and Bairova, Tatyana A and Seitova, Gulnara N and Mordanov, Sergei V and Matulevich, Svetlana A and Nikolaeva, Elena B and Shchagina, Olga A},
  title = {Genotype Structure Alterations in 5q SMA Patients as a Result of the Newborn Screening Program Implementation in the Russian Federation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167891}
}
Kostenlos starten →